Clinical Study

The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals

Table 2

Baseline correlations (Pearson’s regression) of several parameters with ox-LDL, MPO, and Lp-PLA2 activity in subjects with and without the metabolic syndrome ( ).

Variableox-LDL (U/L)MPOa (pM)Lp-PLA2 activity (nmol/mL/min)

Weight (kg)0.1950.0560.2750.0070.2030.047
Waist (in)0.2020.0520.2530.0150.2340.024
BMI (kg/m2)0.1280.2120.3000.0030.0620.544
SBP (mmHg)0.0920.3720.0780.4450.0150.883
DBP (mmHg)0.1960.0550.0230.8220.0660.523
Glucosea (mg/dL)−0.0330.7490.0950.3570.1060.303
Insulina (mU/L)0.1530.1340.2960.0030.0640.536
HOMA-IRa0.1290.2070.2830.0050.0790.445
Triglyceridesa (mg/dL)0.4790.000−0.0180.8580.2920.004
HDL (mg/dL)−0.2310.023−0.1080.292−0.4040.000
LDL (mg/dL)0.6290.000−0.0010.9930.3090.003
Total cholesterol (mg/dL)0.6870.000−0.0520.6120.2970.003
ox-LDL (U/L)0.0040.9680.3780.000
MPOa (pM)0.0040.9680.1170.254
Lp-PLA2 Activity (nmol/mL/min)0.3780.0000.1170.254

Variables are not normally distributed. Log-transformed value before regression.